-
Mayo Clinic And Oxford Nanopore Team Up, Walgreens Collaboration For Heart Disease Clinical Trial, Qnovia Partners With University Of Virginia
Clinical Research News | Mayo Clinic and Oxford Nanopore Technologies unveils a multi-year joint development collaboration to develop new clinical tests for diseases and improve patient care; Walgreens and the Cardiovascular Research Foundation (CRF) announces a collaboration to drive forward the PREVUE-VALVE study, a population-based clinical trial to quantify the prevalence of valvular heart disease (VHD) among older Americans; Qnovia enters a drug development collaboration with the University of Virginia (UVA) to advance novel inhaled-drug candidates for treating bacterial infections in the lungs; and more.
Oct 26, 2023
-
Follow the Money: Harbinger Health’s Cancer-Screening Platform Study, Clinical Developments, In Vivo Reprogramming Therapies, More
Clinical Research News | Harbinger Health funds 10,000-participant clinical study of its novel blood-based cancer screening platform; Nucleus RadioPharma establishes new radiopharmaceuticals manufacturing facilities; HHS funds behavioral health services and HIV prevention for underserved populations; and more.
Oct 25, 2023
-
Multi-Lab Preclinical Model Aims To Solve The Reproducibility Crisis
Clinical Research News | A new preclinical system put to the test by a network of labs to adaptively study a handful of stroke treatments has succeeded in demonstrating that high-quality science is “feasible, practical, and less expensive than doing things the wrong way."
Oct 24, 2023
-
The Opportunities of Big Data Analytics in Clinical Trials
Clinical Research News | The importance of data has become apparent to everybody in recent years. We can now interrogate massive datasets to add value to clinical trials and utilize technology more efficiently to speed up time to market.
Oct 20, 2023
